Evidence map›Paper›PMID 40065363›Full record

ArticleOrphanet journal of rare diseases2025

Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey.

Dina Zucchi, Diana Marinello, Chiara Tani, Giovanni Fulvio, Silvia Aguilera, Alexandra Benachi, Ruth Biller, Ignacio Blanco, Petra Borgards, Marie-Claude Boiteux and 31 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Dina Zucchi *Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy.
Diana Marinello *Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy.
Chiara TaniRheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy.
Giovanni FulvioRheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy.
Silvia AguileraSpanish Association for Antiphospholipid Syndrome (SAF España), ERN ReCONNET, Madrid, Spain.
Alexandra BenachiService de Gynecologie Obstetrique, Hopital Antoine Béclère, AP-HP, Université Paris Saclay, ERN ERNICA, Clamart, France.
Ruth BillerERN GUARD-Heart, Coordinator Center, Amsterdam, The Netherlands.
Ignacio BlancoGermans Trias Hospital, ERN GENTURIS, Badalona, Spain.
Petra BorgardsVASCERN, Coordinator Center, Paris, France.
Marie-Claude BoiteuxCutis Laxa Internationale, ERN-Skin, Bons-en-Chablais, France.
Maria Luisa BrandiUniversità Vita-Salute San Raffaele, ERN BOND, Milan, Italy.
Ester CostafredaSAMS Association, ERN GUARD-Heart, Philadelphia, USA.
Joao E FonsecaServiço de Reumatologia Centro Hospitalar Universitário Lisboa Norte, ERN ReCONNET, Lisbon, Portugal.
Micaela FrediDepartment of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology, University of Brescia, ASST Spedali Civili of Brescia, ERN ReCONNET, Brescia, Italy.
Violeta IotovaDepartment of Pediatrics, UMHAT "St. Marina", Endo-ERN, Varna, Bulgaria.
Simone LouisseERN GUARD-Heart, Coordinator Center, Amsterdam, The Netherlands.
Cecilia NalliDepartment of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology, University of Brescia, ASST Spedali Civili of Brescia, ERN ReCONNET, Brescia, Italy.
Michela OnaliERN Euro-NMD, Coordinator Center, Paris, France.
Beverley PowerCDH UK-The Congenital Diaphragmatic Hernia Charity, ERNICA, King's Lynn, UK.
Christine Rousset-JablonskiDepartment of Surgery, Leon Berard Cancer Center, Lyon, France.
Dominique SturzERN-Eye, Coordinator Center, Strasbourg, France.
Angela TincaniDepartment of Clinical and Experimental Sciences, Rheumatology and Clinical Immunology, University of Brescia, ASST Spedali Civili of Brescia, ERN ReCONNET, Brescia, Italy.
Ana VieiraLiga Portuguesa Contra as Doenças Reumáticas, Núcleo de Sjögren, ERN ReCONNET, Lisbon, Portugal.
Susana CapelaServiço de Reumatologia Centro Hospitalar Universitário Lisboa Norte, ERN ReCONNET, Lisbon, Portugal.
Dorica DanERN ITHACA, Coordinator Center, Paris, France.
Julie De BackerDepartment of Cardiology and Center for Medical Genetics, Ghent University Hospital Belgium, VASCERN, Ghent, Belgium.
Christine de Die-SmuldersGROW, School for Oncology and Reproduction, Maastricht University, ERN NMD, Maastricht, Netherlands.
Andreas DufkeInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Estelle Lecointe ArtznerSarcoma Patients Advocacy Global Network (SPAGN), ERN EURACAN, Berlin, Germany.
Giuseppe LimongelliInherited and Heart Disease Unit, Monaldi Hospital, AO Colli-University of Campania "Luigi Vanvitelli", ERN GUARD-Heart, Naples, Italy.
Birgit LorenzERN-Eye, Coordinator Center, Strasbourg, France.
Wiebke PapenthinERN RARE-LIVER, Wilson Working-Group, Pittsburgh, USA.
María Jesús PascauPaediatric Transplant Unit, La Paz University Hospital, ERN Transplantchild, Madrid, Spain.
Johanna RaidtDepartment of General Pediatrics, University Hospital Muenster, ERN LUNG, Muenster, Germany.
Isabelle Ray-CoquardCentre Leon Bérard, Université Claude Bernard Lyon Est, ERN EURACAN, Lyon, France.
Rachel RimmerERN RITA, Coordinator Center, Utrecht, The Netherlands.
Claas RöhlNF Kinder, Vienna, Austria.
Holm SchneiderUniversity Hospital Erlangen, ERN Skin, Erlangen, Germany.
Tet YapGuy's and St Thomas' NHS Trust, ERN eUROGEN, London, UK.
Rosaria TalaricoRheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy.
Marta MoscaRheumatology Unit, Azienda Ospedaliero Universitaria Pisana and Department of Clinical and Experimental Medicine, University of Pisa, ERN ReCONNET, Via Roma 67, Pisa, Italy. marta.mosca@unipi.it.ORCID http://orcid.org/0000-0001-5937-4574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRare and complex diseases can have a significant impact on family life, and managing the reproductive aspects of patients of childbearing age with rare diseases is often difficult and complex. A European Reference Network (ERN) Transversal Working Group (WG) on Pregnancy and Family Planning was created to join forces to promote and address issues on these topics in rare and low-prevalence diseases.

objectiveTo outline the challenges and the good practices related to pregnancy and family planning in rare and complex diseases for healthcare professionals (HCPs).

methodsA survey on state of the art and unmet needs was created by a co-design group of both clinicians and patients' representatives from 20 ERNs. The survey was uploaded in English on the online platform "EU Survey" and disseminated by respective ERNs and learned societies. Seven transversal domains were explored in the survey by using closed and open-ended questions: fertility preservation, pre-conceptional counselling, family planning counselling, pre-implantation diagnosis, prenatal diagnosis, pregnancy monitoring and post pregnancy monitoring, lactation monitoring/counselling and newborn management. The questions investigated for each topic were the following: level of importance, activities performed by the centre, clinical challenges, good practice and educational activities.

resultsA total of 197 answers were collected from 24 different countries. Unmet needs for HCPs included: the need to improve communication between different HCPs, the lack of predefined organizational pathways, the lack of availability of expert HCPs for some pregnancy-related issues and the need to streamline the care provided among different countries. In addition, the survey underlined the need to improve the educational activities provided to rare disease patients.

conclusionsPhysicians and patients need to be educated on the emerged unmet needs in order to standardize the information for both HCPs and patients with rare diseases. Educational activities should be considered to help to disseminate information.

Indexed as

Family Planning ServicesPregnancy ComplicationsRare DiseasesAdultFemaleHumansPregnancyPrevalenceSurveys and QuestionnairesPregnancy-related issuesRare diseasesUnmet needs

Identifiers

PMID40065363
PMCPMC11892229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.